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Objective. To determine the inﬂuence of age and parity on the surgical management of uterine ﬁbroids, clinical presentation,
presence of pelvic adhesions, cadre of surgeons, and postoperative complications at the Aminu Kano Teaching Hospital, Kano,
Nigeria. Methods. A retrospective analysis of 105 cases of uterine ﬁbroids that were managed between 1st January 2003 and 31st
December 2007. Results. The period prevalence of uterine ﬁbroids was 24.7% of all major gynecological operations. The mean age
was35.8 ±7.6andmeanparity4.7 ±2.8.Abdominalhysterectomyaccountedfor58.1%ofthecasesandmyomectomy41.9%.The
odd of using abdominal hysterectomy was about twice that of myomectomy. Pelvic adhesions were found in 67.6% of the cases.
Menorrhagia (86.7%) was the commonest symptom, while post operative anemia and pyrexia showed signiﬁcant association with
myomectomy. There was no maternal mortality. Conclusion. Surgical operations for uterine ﬁbroids are safe and common kind of
gynecologicaloperationsattheAminuKanoTeachingHospital.Uterineﬁbroidisassociatedmorewithhighparityanddominance
of abdominal hysterectomy over myomectomy, because early girl marriage is common in our community.
1.Introduction
Uterineﬁbroidsarethemostcommonpelvictumourandthe
mostcommonnoncanceroustumorsinwomenofchildbear-
ing age [1]. As many as 1 in 5 women may have ﬁbroids
during their childbearing years, and it usually aﬀect women
over the age of 30 years [1, 2]. It is estimated that 20 to 30%
of women above the age of 30 years harbor uterine ﬁbroids,
which account for 3.2–7.6% of new gynaecological cases and
68.1% of hysterectomies [3–5].
Anincidenceof17.9%–26%hasbeenfoundatlaparosco-
pyinsomeNigerianstudies[6,7],whichismuchhigherthan
11% reported from Europe and the USA [8]. Overexpression
of estrogen receptor (ER) alpha genotype and aromatase,
which has been found to correlate with incidence and size of
uterine ﬁbroids, is particularly pronounced in Afro-Ameri-
can women [9, 10] and may explain why African American
women are at three to ﬁve times greater risk for ﬁbroids
than white women and Negros 3–9 times than Caucasians
[10].Aromataseinhibitorsarecurrentlybeingconsideredfor
prevention and treatment of uterine ﬁbroids [11].
The cause of uterine ﬁbroids is not known, but there
are several risk factors [1, 2]. Known risk factors are Afro-
American descent, nulliparity, obesity, polycystic ovary syn-
drome,diabetes,andhypertension[12,13].Currentworking
hypothesis is that gene predisposition, prenatal hormone
exposure, and eﬀects of hormones, growth factors, and xe-
noestrogens cause ﬁbroid growth [12].
Genetic and hereditary causes are being considered [14,
15]. First degree relatives have 2–5-fold risk, and nearly 6-
fold risk when considering only early onset cases [14]. A
positive family history suggests genetic factors, and a gene
encoding for ﬁbroid development has been suggested [15].
Fibroid growth is strongly dependent on estrogen and
progesterone, which are regarded as growth promoting [16,
17].Paradoxically,ﬁbroidswillrarelygrowduringpregnancy
despite very high steroid hormone levels, and pregnancy
appears to exact a protective eﬀect. The mechanism(s) by2 Obstetrics and Gynecology International
which pregnancy exerts its protective eﬀects is unclear, but
may be mediated by an interaction of estrogen, prostagl-
andins, and oxytocin [18, 19]. This is said to explain why
the incidence of uterine ﬁbroids is decreased with increasing
number of term pregnancies [18], although studies from
Nigeria [5] did not agree with this.
Uterine ﬁbroids, although asymptomatic in many wom-
en, are often detected in women undergoing infertility eval-
uation in many black communities [6, 7]. They tend to give
symptoms from the age of 30 years to the end of the repro-
ductive life [12, 13]. They grow very slowly, but their rate
of growth varies from patient to patient or under diﬀering
circumstances, with 90% of them ceasing to grow or even
regressingafterthemenopause[2],probablybecausetheER-
beta,ER-alpha,andprogesteronereceptorsareoverexpressed
in premenopausal ﬁbroids [14, 20–23].
Hysterectomy which is a major procedure that removes
the uterus is the deﬁnitive treatment for uterine ﬁbroid
[2, 9, 24]. Myomectomy which removes only the ﬁbroids
and leaves the healthy areas of the uterus in place is usually
reserved for women under the age of 40 years, who are of
low parity and desire to maintain their fertility, when the
procedure is surgically feasible and there is a reasonably
good chance of subsequent pregnancy [9, 25–27]. The rates
of hysterectomy for ﬁbroids vary between 32% and 70.4%
[4, 5, 9] and myomectomy between 15.8% and 86% [3–5].
Newer techniques include the use of laser vaporization,
ultrasonic diathermy coagulation to burn the ﬁbroid nod-
ules, and laparoscopic myomectomy for abdominal myo-
mectomy [2]. The use of gonadotrophic releasing hormone
analogs and uterine artery embolization (UAE), which re-
duce the blood supply to the uterus and ﬁbroids, making
them shrink [1, 2], are procedures that would be extremely
popular in developing countries, where the culture often
makes women resent undergoing major surgery or losing
theiruterus[9].However,theexpensiveequipmentsandcost
of the procedures make them often out of the reach of most
developing countries [9].
It is evident that the determining factors in the man-
agement of uterine ﬁbroids and the outcome of treatment
vary widely in diﬀerent communities. It is therefore the
purpose of this study to determine the factors that inﬂuence
the management of uterine ﬁbroids in our community, the
presentation and outcome.
2.MaterialandMethods
A retrospective analysis of 105 cases of uterine ﬁbroids that
were managed at the Aminu Kano Teaching Hospital, Kano,
Nigeria, between the 1st January 2003 and 31st December
2007. The patients’ identiﬁcation data were retrieved from
the gynecological ward admission and discharge record
books and theatre’s operation register. Their case notes
were retrieved from the Medical Records Department and
analyzed for incidence, age, parity, clinical presentation,
presence of pelvic adhesions, type of surgical treatment, and
postoperative complications.
During the study period, myomectomy was done using
the tourniquet method, in which a tourniquet was applied
around the lower uterine segment and below the ﬁbroids,
to achieve mechanical vasoconstriction on the ascending
uterine artery bilaterally [28, 29]. A tourniquet time was
kept, and the tourniquet was released after 30 minutes and
reapplied after 5 minutes to reestablish blood ﬂow and
prevent irreversible damage to the uterine muscle cells [28,
29].
Postoperatively, a packed cell volume of less than 30%
was considered as anemia, a temperature of 38◦Co rm o r e
on two consecutive days after the ﬁrst post operative day
was considered as pyrexia, dysuria and/or frequency of mic-
turtionwithpositiveurinemicrobiologyculturewastakenas
urinary tract infection (UTI), and local erythema or suppu-
ration was considered as wound infection.
The data obtained were recorded using tables. Statistical
analysis was done with Chi-square test using a commercial
statisticalpackage(SPSS/PCversion11.0,SPSSInc.,Chicago,
Ill, USA).
The odds ratio (OR) and 95% conﬁdence interval (CI)
were determined where appropriate. A P value of less than
0.05 was considered signiﬁcant.
3. Results
During the study period, surgical operations for uterine
ﬁbroids were carried out in 115 cases out of 465 major gyne-
cological operations that were performed, giving a period
prevalence of 24.7% of major gynecological operations for
uterine ﬁbroids. Only 105 case notes were retrieved from
the Medical Records Department giving a retrieval rate of
91.3%. Abdominal hysterectomy was performed in 58.1%
of the cases, while 41.9% had abdominal myomectomy, the
odd of using abdominal hysterectomy was about twice that
of myomectomy (OR = 1.92. CI = 1.07–3.46, P<0.05).
There was no case of vaginal hysterectomy or endoscopic
surgery, and all the hysterectomies were total abdominal
hysterectomy. Pelvic adhesions were found in 67.6% of the
cases, while 32.4% had clean pelvic cavity. All the surgeries
were done with consultant gynecologists participating.
Theagerangeamongthepatientswas26–55years,witha
meanageof35.8 ±7.6.Thehighestfrequency(65.7%)wasin
the 30–34-year age group, while the least (6.7%) was among
the 25–29-year age group. The odd of having hysterectomy
was highest among 35–39-year age group (OR = 5.72, CI =
1.43–26.52, P<0.05), while there was no statistically
signiﬁcant diﬀerence in the odd of having hysterectomy
or myomectomy among the 30–34-year age group (OR =
0.40, CI = 0.15–1.02, P>0.05). All the patients in the
20–29-year age group had myomectomy, while the only
nulliparous patients among the 40-year-or-more age group
had hysterectomy Table 1.
The parity range was from 0 to 12, with a mean parity of
4.7 ± 2.8. Among the patients, 6.7% were nulliparous, while
93.3% were of parous, with at least one living child. Among
them, 33 women (31.4%) were grand multiparae, which
accounted for the highest frequency among the patients,
while the least frequency was among the nulliparae. The
use of hysterectomy was signiﬁcantly higher among Para 4
and Para ≥5, while myomectomy was signiﬁcantly higherObstetrics and Gynecology International 3
Table 1: Age and type of operation performed.
Age (years) Hysterectomy Myomectomy OR CI P Value
25–29 — 6 — — Signiﬁcant∗∗
25–29 35 34 0.40 0.15–1.02 >0.05 (NS)
35–39 17 3 5.80 1.32–24.59 <0.05∗
≥40 9 1 7.44 0.90–163.00 <0.05∗
Total 61 (58.1) 44(41.9) 1.92 1.07–3.46 <0.05∗
∗Statistically signiﬁcant for hysterectomy
∗∗Statistically signiﬁcant for myomectomy
NS: Not statistically signiﬁcant.
Table 2: Parity and type of operation performed on the patient.
Parity Hysterectomy Myomectomy OR CI P value
O 2 5 0.26 0.03–1.65 <0.05∗∗
1 3 8 0.23 0.05–1.06 <0.05∗∗
2 3 10 0.18 0.04– 0.76 <0.05∗∗
3 12 18 0.35 0.13–0.92 < 0.05∗∗
4 13 2 5.69 1.12–38.84 <0.05∗
≥5 28 1 36.48 4.85–757.27 <0.05∗
Total 61 (58.1) 44(41.9) 1.92 1.07–3.46 <0.05∗
∗Statistically signiﬁcant for hysterectomy
∗∗Statistically signiﬁcant for myomectomy.
Table 3: Clinical presentation of patients.
Presentation Frequency n (%)
(i) Menstrual abnormalities 91 (86.7)
(ii) Abdominal swelling 64 (61.0)
(iii) Lower abdominal pain 58 (55.2)
(iv) Dysmenorrhoea 40 (38.1)
(v) Infertility 25 (23.8)
Primary 5 (20.0)
Secondary 20 (80.0)
among Para 0–2. There was no signiﬁcant diﬀerence in the
use of hysterectomy or myomectomy among Para 3. Two
nulliparous women in the 30–34-year age group had hys-
terectomy, because of huge ﬁbroid and technical diﬃculties
that were encountered during myomectomy. Table 2.
Menorrhagia (86.7%) was the commonestsymptom, fol-
lowed by abdominal swelling (61.0%), lower abdominal pain
(55.2%), and dysmenorrhoea (38.1%). Infertility (23.8%)
accounted for the least frequency, with majority of them
(80.0%) having secondary infertility Table 3.
Postoperative anemia (41.0%) was the most common
complication, followed by post operative pyrexia (33.3%),
UTI (8.6%), and wound infection (15.2%). Postoperative
anemia (OR = 5.37, CI = 2.13–13.77, P<0.05), and pyrexia
(OR = 4.47, CI = 1.74–11.70, P<0.05), showed statistically
signiﬁcantassociationwithmyomectomy.Postoperativeane-
mia occurred 5 times more, while postoperative pyrexia
occurred 4 times more among patients who had myomec-
tomy compared to hysterectomy. There was no statistically
signiﬁcant diﬀerence (P>0.05) in the frequency of urinary
tract infection (UTI) and wound infection in the two groups
Table 4. There was no maternal mortality.
4. Discussion
The period prevalence of 24.7% of major gynaecological
operations for uterine ﬁbroids in this study is similar to the
ﬁndings in other studies from Nigeria [27], but lower than
r e p o r t sf r o mE u r o p e[ 8], probably because uterine ﬁbroid is
more common among the black race [9].
In this study, uterine ﬁbroids occurred most often in the
third decade of life, which agrees with the ﬁndings of other
studies [27, 30, 31], which may probably be because uterine
ﬁbroids is uncommon before the age of 30 years and after
menopause [9].
Majority of the patients were of high parity because of
early girl marriage and childbearing in our community, and
uterineﬁbroidwasassociatedmorewithsecondaryinfertility
in this study, which does not agree with the ﬁndings in
the study from Ilorin [27] in north-Central Nigeria, Enugu
[31], and Abakaliki [32] in-south-eastern Nigeria, and Addis
Ababa in Ethiopia [30], where women delay marriage, and
uterine ﬁbroid is associated more with low parity and
primary infertility [27, 32]. This may be because prolonged
periods of voluntary infertility from delayed age of marriage
are usually associated with development of uterine ﬁbroids
and primary infertility [1, 2]. This may also explain why
the overall hysterectomy rate was twice as much as that of
myomectomy in this study, while myomectomy was used
morethanhysterectomyin thestudyfromIlorin [27],Enugu
[31] and Abakaliki [32] in Nigeria and Addis Ababa in
Ethiopia [30]. A Study from Gombe [33] in-north-eastern
Nigeria, which is also predominantly Islamic communities4 Obstetrics and Gynecology International
Table 4: Postoperative Complications.
Complication
Frequency n (%)
Myomectomy Hysterectomy OR CI P-value
n = 44 n = 61
Anaemia 28 15 5.37 2.13–13.77 <0.05∗
Fever 23 12 4.47 1.74–11.70 <0.05∗
UTI 4 5 1.12 0.23–5.22 >0.05
Wound infection 9 7 1.98 0.60–6.61 >0.05
∗Statistically signiﬁcant.
like ours, where early girl marriage is common, recorded low
frequency of nulliparity among their hysterectomy patients,
majority of whom had uterine ﬁbroids, compared to similar
study from Ibadan [34] in-south-west Nigeria where women
delay marriage, in which uterine ﬁbroids was also the
commonest indication.
Majority of the women had pelvic adhesions, which
agree with other studies from Nigeria [7, 26, 27]. The high
association of uterine ﬁbroids withpelvic adhesions has been
attributed to the high prevalence of pelvic inﬂammatory
disease (PID), previous caesarean section, and laparotomy in
developing countries [26, 33], which may cause tubal disease
and contribute to the signiﬁcant association with infertility
[1, 2]. Early girl marriage and childbearing in our com-
munity before the age when uterine ﬁbroids are common
may explain why menorrhagia was the commonest clinical
presentation and infertility the least in this study, while
infertility(mainlyprimary)wasthecommonestclinicalpres-
entation in the study from Ilorin [27] and Abakaliki [32]i n
Nigeria, where women delay marriage and childbearing.
The high association of uterine ﬁbroids with pelvic
inﬂammatorydiseaseandpelvicadhesions, andthelargesize
of most ﬁbroids in developing countries [9]h a sb e e nf o u n d
to be the reason why vaginal hysterectomy is not commonly
employed in the management of uterine ﬁbroids, because of
the technical diﬃculties that may be involved [9]. This may
explain why vaginal hysterectomy was not employed in the
managementofuterineﬁbroidsinthisstudy.Withtheadvent
oflaparoscopic-assistedvaginalhysterectomyinourhospital,
smaller ﬁbroids may be removed per vaginam.
There was no case of hysterectomy carried out among
women who were less than 30 years, probably because hys-
terectomy among women in that age group is not done for
emotional reasons [9]. Two nulliparous women had hys-
terectomy, because of huge uterine ﬁbroids and technical
diﬃculties at surgery. Huge uterine ﬁbroid as a result of
delay in presentation is a common occurrence in developing
countries like Nigeria and has been reported to be a cause
of emergency hysterectomy as a result of technical diﬃcul-
ties encountered during myomectomy [34], which further
emphasizes the need to obtain consent for hysterectomy in
addition, before embarking on myomectomy.
Most of the women aged ≥40 years had hysterectomy,
because they were parous, and also because of the low prob-
ability of further pregnancies at that age compared to future
complications [9], which advised in favour of hysterectomy,
in order to give them good quality of life. The only case of
myomectomy among the 40-year-and-above age group, was
the only case of primary infertility in that group, so as to
enable her to beneﬁt from in vitro fertilization and embryo
transfer, which she can aﬀord and agreed to during preop-
erative counseling. Myomectomy and recourse to IVF-ET is
a possibility that is currently being explored in the man-
agement of uterine ﬁbroids in older women with primary
infertility [27].
Postoperative anaemia and pyrexia were the commonest
postoperative morbidity, which agrees with other studies
[1, 2]. Postoperative anaemia and pyrexia occurred more
with myomectomy than hysterectomy, which may probably
be due to bleeding into the ﬁbroid cavities and peritoneum,
with resultant reactionary pyrexia following myomectomy
[2], so eﬀort must be made to obliterate all dead spaces at
surgery [1, 2].
T h eh i g h e rf r e q u e n c yo fc o m p l i c a t i o n sw i t hm y o m e c -
tomy compared to hysterectomy in this study agree with
other studies [2]. This can be reduced by using endoscopic
methods like da Vinci Myomectomy, which is a new cat-
egory of minimally invasive myomectomy, and the latest
evolution in robotics technology, which combines the best
of open and laparoscopic surgery [35]. With minimally
invasive myomectomy using endoscopic methods, surgeons
can remove uterine ﬁbroids through small incisions with
unmatched precision and control, and carry out comprehen-
sive reconstruction of the uterine wall, regardless of the size
or location of the ﬁbroids. Among the potential beneﬁts of
minimally invasive myomectomy using endoscopic methods
ascomparedtotraditionalopenabdominalsurgeryarebetter
opportunity for future pregnancy, signiﬁcantly less pain,
less blood loss, fewer complications with less scarring and
possibility of uterine rupture during future pregnancies, a
shorter hospital stay, and a faster return to normal daily
activities [35]. We advocate the introduction of minimally
invasive myomectomy using endoscopic methods in health
facilities that perform myomectomy.
Wound infection and urinary tract infection which did
not show statistically signiﬁcant diﬀerence between myo-
mectomy and hysterectomy cases may be a result of poor
environmental and personal hygiene in our community in a
developing country, and urethral catheterization, which has
been known to predispose postoperative patients to urinary
tract infection [9].
Theuterinetourniquetwhichwasappliedroundthelow-
er uterine segment and below the ﬁbroids during myomec-
tomy in this study, is a mechanical vaso-occlusive techniqueObstetrics and Gynecology International 5
to achieve mechanical vasoconstriction on the ascending
uterine artery bilaterally [28, 29]. It has been found to be
associated with low risk of haemorrhage and diﬃculty with
securing haemostasis, as well as postoperative morbidity,
shorter mean duration of operation and hospital stay [28,
29]. This may explain why only two cases of myomectomy
were abandoned for hysterectomy, because of diﬃculty dur-
ing the operation in this study.
There was no maternal mortality, probably because of
meticulous care and the surgeries were done with consultant
gynecologists participating. This calls for consultant’s partic-
ipation in surgeries for uterine ﬁbroids.
5. Conclusion andRecommendations
Surgical operations for uterine ﬁbroids are common gynae-
cological operations at the Aminu Kano Teaching Hospital.
Myomectomy and hysterectomy which are the only modal-
ities of management of uterine ﬁbroids that are presently
available are safe and eﬀective, the choice of which should be
individualizedamongthepatients.Communitieswhereearly
girl marriage and childbearing is practiced should expect
uterine ﬁbroids to be associated more with high parity, and
dominance of abdominal hysterectomy over myomectomy.
Introduction of minimally invasive myomectomy using
endoscopic methods may reduce the higher frequency of
complications that are associated with myomectomy, and
laparoscopic-assisted vaginal hysterectomy may make small-
er ﬁbroids to be removed per vaginam.
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